| 2026-08-07 | Press release | Pacira BioSciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) |
| 2026-08-06 | Press release | Pacira BioSciences Announces Publication of Positive Two-Year Phase 1 Data For PCRX-201 in Annals of the Rheumatic Disea |
| 2026-08-04 | Transcript | Q2 FY26 earnings call transcript |
| 2026-08-04 | Press release | Pacira BioSciences Reports Second Quarter 2026 Financial Results |
| 2026-08-04 | 8-K | Form 8-K, Item 2.02 results |
| 2026-08-04 | 10-Q | Form 10-Q for the quarter ended Jun 30 |
| 2026-08-04 | Transcript | Q2 FY26 earnings call transcript |
| 2026-07-28 | Press release | Pacira BioSciences Announces New National Survey Revealing the Hidden Toll of Pain on America’s Workforce |
| 2026-07-27 | Press release | Pacira BioSciences Advances PCRX-201 Development Program with Successful Transition to Scalable Commercial Manufacturing |
| 2026-07-22 | Press release | Pacira to Report Second Quarter 2026 Financial Results on Tuesday August 4, 2026 |
| 2026-07-08 | Press release | Pacira BioSciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) |
| 2026-07-06 | Press release | Pacira BioSciences Joins Life Science Cares as National Corporate Partner |
| 2026-07-01 | Press release | Pacira BioSciences Announces UnitedHealthcare Now Provides Separate Reimbursement for EXPAREL® |
| 2026-06-30 | Press release | Pacira BioSciences Announces Agreement to Divest its iovera° Business to Zimmer Biomet |
| 2026-06-30 | 8-K | Form 8-K, Item 1.01 |
| 2026-06-11 | 8-K | Form 8-K, Item 5.02 |
| 2026-04-30 | Deck | 1Q 2026 Earnings Presentation |
| 2026-04-30 | 8-K | Form 8-K, Item 2.02 results |
| 2026-04-30 | 10-Q | Form 10-Q for the quarter ended Mar 31 |
| 2026-03-02 | Transcript | Q4 FY25 earnings call transcript |
| 2026-02-26 | Deck | 4Q 2025 Earnings Presentation |
| 2026-02-26 | 8-K | Form 8-K, Item 2.02 results |
| 2026-02-26 | 10-K | Annual report on Form 10-K, FY25 |
| 2026-01-28 | 8-K | Form 8-K, Item 5.02 |
| 2026-01-14 | Deck | 44th Annual J.P. Morgan Healthcare Conference Presentation |
| 2026-01-08 | 8-K | Form 8-K, Item 2.02 results |
| 2025-11-06 | 8-K | Form 8-K, Item 2.02 results |
| 2025-11-06 | 10-Q | Form 10-Q for the quarter ended Sep 30 |
| 2025-11-05 | Deck | 3Q 2025 Earnings Presentation |
| 2025-08-05 | Deck | Investor presentation · Q2 2025 · Aug 2025 |
| 2025-08-05 | 8-K | Form 8-K, Item 2.02 results |
| 2025-08-05 | 10-Q | Form 10-Q for the quarter ended Jun 30 |
| 2025-07-10 | 8-K | Form 8-K, Item 2.05 |
| 2025-07-07 | 8-K | Form 8-K, Item 1.01 |
| 2025-06-13 | 8-K | Form 8-K, Item 5.02 |
| 2025-05-08 | 8-K | Form 8-K, Item 2.02 results |
| 2025-05-08 | 10-Q | Form 10-Q for the quarter ended Mar 31 |
| 2025-05-07 | Deck | 1Q 2025 Earnings Presentation |
| 2025-04-29 | Proxy | Definitive proxy statement |
| 2025-04-22 | 8-K | Form 8-K, Item 8.01 |